Inverse association between glutathione peroxidase activity and both selenium-binding protein 1 levels and gleason score in human prostate tissue

Prostate

Volumn 72, Issue 9, 2012, Pages 1006-1012

  Jerome Morais, Anita ^a   Wright, Margaret E ^a   Liu, Rui ^a   Yang, Wancai ^a   Jackson, Matthew I ^b   Combs Jr , Gerald F ^b   Diamond, Alan M ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

Gleason score; GPx; prostate; SBP1; selenium

Indexed keywords

GLUTATHIONE PEROXIDASE; SELENIUM; SELENIUM BINDING PROTEIN; SELENOPROTEIN;

ADULT; AFRICAN AMERICAN; AGGRESSIVENESS; ARTICLE; BLOOD ANALYSIS; CANCER CELL CULTURE; CANCER LOCALIZATION; CANCER PROGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DENSITOMETRY; DIET RESTRICTION; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; GLEASON SCORE; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; STATISTICAL SIGNIFICANCE; TISSUE LEVEL; WESTERN BLOTTING;

AGED; CELL DIFFERENTIATION; ENZYME ACTIVATION; GLUTATHIONE PEROXIDASE; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; PROSTATE; PROSTATIC NEOPLASMS; SELENIUM-BINDING PROTEINS; TUMOR MARKERS, BIOLOGICAL;

EID: 84861100409     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.21506     Document Type: Article

References (26)

1. World Cancer Research Fund, American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: A global perspective. Washington, DC: WCRF/AICR; 2007. p. xxv, 517.
2. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD III, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL Jr, Baker LH, Coltman CA Jr., Effect of selenium and vitamin E on risk of prostate cancer and other cancers: The Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009; 301 (1): 39-51.
3. Kryukov GV, Castellano S, Novoselov SV, Lobanov AV, Zehtab O, Guigo R, Gladyshev VN,. Characterization of mammalian selenoproteomes. Science 2003; 300 (5624): 1439-1443.
4. Baliga MS, Wang H, Zhuo P, Schwartz JL, Diamond AM,. Selenium and GPx-1 overexpression protect mammalian cells against UV-induced DNA damage. Biol Trace Elem Res 2007; 115 (3): 227-242.
5. Zhuo P, Goldberg M, Herman L, Lee BS, Wang H, Brown RL, Foster CB, Peters U, Diamond AM,. Molecular consequences of genetic variations in the glutathione peroxidase 1 selenoenzyme. Cancer Res 2009; 69 (20): 8183-8190.
6. Zhuo P, Diamond AM,. Molecular mechanisms by which selenoproteins affect cancer risk and progression. Biochim Biophys Acta 2009; 1790 (11): 1546-1554.
7. Bansal MP, Oborn CJ, Danielson KG, Medina D,. Evidence for two selenium-binding proteins distinct from glutathione peroxidase in mouse liver. Carcinogenesis 1989; 10 (3): 541-546.
8. Yang VW, Shields JM, Hamilton SR, Spannhake EW, Hubbard WC, Hylind LM, Robinson CR, Giardello FM,. Size-dependent increase in prostanoid levels in adenomas of patients with familial adenomatous polyposis. Cancer Res 1998; 58: 1750-1753.
9. Yuen ST, Davies H, Chan TL, Ho JW, Bignell GR, Cox C, Stephens P, Edkins S, Tsui WW, Chan AS, Futreal A, Stratton MR, Wooster R, Leung SY,. Similarity of the phenotypic patterns associated with BRAF and KRAS mutations in colorcetal neoplasia. Cancer Res 2002; 62: 6451-6455.
10. Huang KC, Park DC, Ng SK, Lee JY, Ni X, Ng WC, Bandera CA, Welch WR, Berkowitz RS, Mok SC, Ng SW,. Selenium binding protein 1 in ovarian cancer. Int J Cancer 2006; 118 (10): 2433-2440.
11. Chen G, Wang H, Miller CT, Thomas DG, Gharib TG, Misek DE, Giordano TJ, Orringer MB, Hanash SM, Beer DG,. Reduced selenium-binding protein 1 expression is associated with poor outcome in lung adenocarcinomas. J Pathol 2004; 202 (3): 321-329.
12. Kim H, Kang HJ, You KT, Kim SH, Lee KY, Kim TI, Kim C, Song SY, Kim HJ, Lee C, Kim H,. Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival. Proteomics 2006; 6 (11): 3466-3476.
13. Li T, Yang W, Li M, Byun DS, Tong C, Nasser S, Zhuang M, Arango D, Mariadason JM, Augenlicht LH,. Expression of selenium-binding protein 1 characterizes intestinal cell maturation and predicts survival for patients with colorectal cancer. Mol Nutr Food Res 2008; 52 (11): 1289-1299.
14. Fang W, Goldberg ML, Pohl NM, Bi X, Tong C, Xiong B, Koh TJ, Diamond AM, Yang W,. Functional and physical interaction between the selenium-binding protein 1 (SBP1) and the glutathione peroxidase 1 selenoprotein. Carcinogenesis 2010; 31 (8): 1360-1366.
15. Jemal A, Siegel R, Xu J, Ward E,. Cancer statistics, 2010. CA Cancer J Clin 2010; 60 (5): 277-300.
16. Gleason DF, Mellinger GT,. Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol 1974; 111 (1): 58-64.
17. Samuels BA, Murray JL, Cohen MB, Safa AR, Sinha BK, Townsend AJ, Beckett MA, Weichselbaum RR,. Increased glutathione peroxidase activity in human sarcoma cell line with inherent doxorubicin resistance. Cancer Res 1991; 51: 521-527.
18. Takata Y, Morris JS, King IB, Kristal AR, Lin DW, Peters U,. Correlation between selenium concentrations and glutathione peroxidase activity in serum and human prostate tissue. Prostate 2009; 69 (15): 1635-1642.
19. Ashton K, Hooper L, Harvey LJ, Hurst R, Casgrain A, Fairweather-Tait SJ,. Methods of assessment of selenium status in humans: A systematic review. Am J Clin Nutr 2009; 89 (6): 2025S-2039S.
20. Jemal A, Center MM, DeSantis C, Ward EM,. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 2010; 19 (8): 1893-1907.
21. Pohl NM, Tong C, Fang W, Bi X, Li T, Yang W,. Transcriptional regulation and biological functions of selenium-binding protein 1 in colorectal cancer in vitro and in nude mouse xenografts. PLoS ONE 2009; 4 (11): e7774.
22. Lu YP, Lou YR, Yen P, Newmark HL, Mirochnitchenko OI, Inouye M, Huang MT,. Enhanced skin carcinogenesis in transgenic mice with high expression of glutathione peroxidase or both glutathione peroxidase and superoxide dismutase. Cancer Res 1997; 57 (8): 1468-1474.
23. Gouaze V, Andrieu-Abadie N, Cuvillier O, Malagarie-Cazenave S, Frisach MF, Mirault ME, Levade T,. Glutathione peroxidase-1 protects from CD95-induced apoptosis. J Biol Chem 2002; 277 (45): 42867-42874.
24. Gouaze V, Mirault ME, Carpentier S, Salvayre R, Levade T, Andrieu-Abadie N,. Glutathione peroxidase-1 overexpression prevents ceramide production and partially inhibits apoptosis in doxorubicin-treated human breast carcinoma cells. Mol Pharmacol 2001; 60 (3): 488-496.
25. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ,. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993; 75 (2): 241-251.
26. Brigelius-Flohe R, Kipp A,. Glutathione peroxidases in different stages of carcinogenesis. Biochim Biophys Acta 2009; 1790 (11): 1555-1568.